Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome- |
RCV001580627 | SCV001810269 | uncertain significance | Argininosuccinate lyase deficiency | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002570823 | SCV003572640 | uncertain significance | Inborn genetic diseases | 2021-07-20 | criteria provided, single submitter | clinical testing | The c.1165G>A (p.E389K) alteration is located in exon 16 (coding exon 15) of the ASL gene. This alteration results from a G to A substitution at nucleotide position 1165, causing the glutamic acid (E) at amino acid position 389 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |